| Patient | Fannie Lou Hamer |
|---|---|
| Date of birth | 1976-10-06 |
| Identifiers | MRN HR-ML031-SYN; SSN (made up) 000-31-2479 |
| Document date | 2026-03-23 |
| Author | Cornelius Agbaje, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Albumin in the urine and mildly reduced kidney function in a 49-year-old woman with newly diagnosed type 2 diabetes, high blood pressure readings awaiting home confirmation, and kidneys injured in a beating years ago. Please advise on the cause, the need for imaging, kidney-protective treatment, and monitoring. A telehealth visit from our health center is requested, because the trip to the regional hospital is long and she has no car. [S]
Urgency: Within two weeks, by telehealth on the day of her two-week visit, with our community health worker present. [S]
Questions for the consultant:
Mrs. Hamer, 49, is seen by video from the community health center at the request of Dr. Batiste-Hill, with the community health worker beside her and her consent to the telehealth visit. She describes injuries to her kidneys and left eye from a beating years ago, and back and leg aching since. She has had thirst and frequent urination for some months, easing on metformin. Her home blood pressure readings over seven days average 152/94. She takes no NSAIDs. She has no blood in the urine, no kidney stones and no known family kidney disease. She said she would agree to treatment if each medicine and its purpose were explained, and asked what the medicines would cost. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening meal | Two tablets with the evening meal (after one week of one tablet) | Oral route | 2026-03-09 to 2026-07-13 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-09 | active | S |
| Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule daily | One capsule daily | Oral route | 2026-03-23 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgery | One tablet daily, with sick-day rules | Oral route | 2026-03-23 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later life | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes is documented only at the end of her life. |
| Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigated | resolved | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented. |
| Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later life | active | confirmed | I12.9 | S — Synthetic modern diagnosis; hypertension is reported only at the end of her life. |
| Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contribute | active | confirmed | N18.2 | S — Synthetic kidney findings anchored to the documented permanent kidney damage. |
| Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention) | active | confirmed | E11.22 | S — Synthetic modern coding. |
| Food insecurity: food runs out before the end of most months | active | confirmed | Z59.41 | S — Synthetic social need found on the screen. |
| Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrange | active | confirmed | Z59.82 | S — Synthetic social need anchored to her rural Delta home. |
| Hyperlipidemia: LDL 146 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
Vital signs recorded on 2026-03-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | By video: comfortable and engaged, speaking in full sentences |
| Vital signs | Blood pressure 156/96 and pulse 82, measured by the clinic nurse today |
| Extremities | No ankle swelling, as examined by Dr. Batiste-Hill today |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-23 | Albumin/Creatinine [Mass Ratio] in Urine | 96 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
Data reviewed: Dr. Batiste-Hill's intake note and results: creatinine 0.96 mg/dL, eGFR 73; potassium 4.3 mmol/L; urine albumin-to-creatinine ratio 88 mg/g at intake and 96 mg/g this morning; A1c 8.6%; LDL 146 mg/dL; ECG without left ventricular hypertrophy. Kidney ultrasound this morning: right kidney 9.0 cm with a lower-pole cortical scar, left kidney 11.4 cm and normal, no hydronephrosis or stones. Home blood pressure average 152/94; clinic 156/96 today. [S]